Twist Bioscience
TWST
246 hedge funds and large institutions have $2.99B invested in Twist Bioscience in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 91 increasing their positions, 77 reducing their positions, and 50 closing their positions.
193% more call options, than puts
Call options by funds: $5.94M | Put options by funds: $2.02M
18% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 77
0.55% less ownership
Funds ownership: 113.33% → 112.77% (-0.55%)
6% less funds holding
Funds holding: 263 → 246 (-17)
8% less capital invested
Capital invested by funds: $3.25B → $2.99B (-$264M)
32% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 50
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$46.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$25M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.8M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$20.4M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$36.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.2M |
| 3 |
JP Morgan Chase
New York
|
-$21.4M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.2M |
| 5 |
Millennium Management
New York
|
-$15.5M |
TWST Hedge Fund Activity: Q3 2024 in Review
246 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2024, worth a combined $2.99B — down 8.1% from $3.25B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of TWST and 34 opened new positions — a net loss of 16 holders — while 77 trimmed existing stakes and 91 added.
The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $46.3M. The largest seller was ARK Investment Management, cutting an estimated $36.7M.
- 246 institutional investors held Twist Bioscience (TWST) as of Q3 2024, down from 263 in Q2 2024.
- Funds reported $2.99B of Twist Bioscience stock for Q3 2024, down 8.1% quarter-over-quarter.
- 34 funds opened new Twist Bioscience positions in Q3 2024 and 50 closed out, a net change of -16 holders.
- The largest Twist Bioscience buyer in Q3 2024 was Thrivent Financial for Lutherans, an estimated $46.3M added.
- The largest Twist Bioscience seller in Q3 2024 was ARK Investment Management, an estimated $36.7M sold.
Based on aggregated 13F filings for Q3 2024.